The move targets harnesses—software wrappers that pilot a user’s web-based Claude account via OAuth to drive automated ...

O n Tuesday, researchers at Stanford and Yale revealed something that AI companies would prefer to keep hidden. Four popular ...

For users whose work is scattered across half a dozen (or more) websites, LinkNotch handles the system resource conundrum and ...

Students continue to pursue postsecondary education—particularly Latino and Black students—and a growing share of those applicants are choosing to submit SAT and ACT scores even when institutions are ...

In today's rapidly evolving identity landscape, organizations are accelerating their adoption of cloud-first strategies (specifically by modernizing identity infrastructure through the adoption of ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. As Isomorphic Labs aims its artificial ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Until now, cells dividing by mitosis were thought to grow round and then split into two identical, spherical daughter cells. New research has found that some cells are isomorphic, meaning they retain ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Isomorphic Labs, a young company whose artificial intelligence technology for drug research has already landed partnerships with big pharmaceutical companies, unveiled $600 million in new financing ...